文献速递神经肿瘤神经重症

基于加速康复外科的脑肿瘤术后疼痛管理护理路径的构建与应用

Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients.
PubMed 文献 · J Neurooncol · 2026-01-30

本研究分两阶段:第一阶段收集532例脑肿瘤手术患者数据,分析中重度术后疼痛(NRS≥4)的危险因素,并结合多因素分析与ERAS原则制定护理路径;第二阶段将100例患者随机分为ERAS组与对照组(每组50例),比较疼痛评分、镇痛消耗、功能恢复、住院时间、并发症及护理满意度。结果显示ERAS组术后第1/3/5天NRS评分更低(P<0.01),镇痛消耗和补救镇痛需求减少,首次下床更早,住院时间缩短,并发症无差异,护理满意度更高。

要点

  • 高血压、术前头痛、焦虑、抑郁、睡眠差、手术≥6小时、围术期激素、下床延迟、术后24h恶心呕吐为独立危险因素。
  • ERAS护理路径可降低脑肿瘤患者术后第1/3/5天NRS评分(P<0.01)。
  • ERAS组镇痛消耗和补救镇痛减少,首次下床更早,住院时间缩短,护理满意度更高。

核心结论

  • 基于ERAS的护理路径可有效缓解脑肿瘤患者术后疼痛,减少镇痛需求,加速康复,提高满意度,且不增加并发症风险。

研究设计与样本

  • 第二阶段(2025年1月至2025年6月)将100例脑肿瘤患者随机分为ERAS组和对照组,每组50例,比较术后结局。

主要发现

  • 多因素分析确定高血压、术前头痛、焦虑、抑郁、睡眠质量差、手术时长≥6小时、围术期使用皮质类固醇、首次下床延迟、术后24小时内恶心呕吐(PONV)为中重度疼痛的独立危险因素。
  • 与对照组相比,ERAS组术后第1/3/5天NRS评分更低(P<0.01),每日镇痛消耗量和补救镇痛请求更少。
  • ERAS组首次下床时间显著更早,住院时间缩短。
  • 两组并发症发生率无统计学差异,但ERAS组护理满意度显著更高。

关键数值与推荐

  • 中重度术后疼痛定义为NRS评分≥4。
  • ERAS组术后第1/3/5天NRS评分低于对照组(P<0.01)。
  • ERAS组每日镇痛消耗量和补救镇痛请求少于对照组。
  • ERAS组首次下床时间早于对照组,住院时间短于对照组。
  • 两组并发症发生率无统计学差异,ERAS组护理满意度显著高于对照组。

临床怎么用

  • 可将高血压、术前头痛、焦虑、抑郁、睡眠差、手术时长≥6小时、围术期激素使用、下床延迟及术后24h PONV作为中重度疼痛高危因素进行筛查。
  • 基于ERAS原则制定护理路径,用于脑肿瘤患者术后疼痛管理,以降低疼痛评分、减少镇痛消耗、促进早期下床和缩短住院时间。
  • 实施ERAS护理路径时无需担心增加并发症风险,且可提高护理满意度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To construct an enhanced recovery after surgery (ERAS)-based nursing pathway for postoperative pain management in brain tumor patients and to evaluate its clinical efficacy. METHODS: This study was conducted in two phases. In the first phase (June 2022-December 2024), clinical data from 532 patients receiving brain tumor surgery were collected to analyze risk factors for moderate-to-severe postoperative pain (NRS score ≥ 4). A nursing pathway was developed by integrating the results of multivariate analysis with ERAS principles. In the second phase (January 2025-June 2025), 100 brain tumor patients were randomized to ERAS or control group (n = 50/group). Postoperative outcomes, including pain scores, daily analgesic consumption, functional recovery, hospital stay, complications, and nursing satisfaction, were compared. RESULTS: Multivariate analysis identified hypertension, preoperative headache, anxiety, depression, poor sleep quality, operative duration ≥ 6 h, perioperative corticosteroid use, delayed first ambulation, and postoperative nausea and vomiting (PONV) within 24 h as independent risk factors for moderate-to-severe pain. Compared to controls, the ERAS group demonstrated lower NRS scores on postoperative day 1/3/5 (P < 0.01), reduced daily analgesic consumption and fewer rescue analgesia requests. Time to first ambulation occurred significantly earlier and hospital stay was shortened in the ERAS group. No statistical difference was observed in complication rates; however, nursing satisfaction was significantly higher in the ERAS group. CONCLUSION: ERAS-based nursing pathway effectively alleviates postoperative pain, reduces analgesic requirements, accelerates recovery, and enhances satisfaction in brain tumor patients without increasing complication risks, demonstrating substantial clinical utility and potential for broader implementation.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Qiu H, Huang Y, Zhou J, et al. Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients. J Neurooncol. 2026. PMID: 41618043. doi:10.1007/s11060-026-05444-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。